Former FDAer: COVID Shows Fast Authorizations Work, But Better Surveillance Needed

By Jessica Karins / November 21, 2022 at 3:41 PM
Health care can benefit from the streamlined FDA authorization processes used during the pandemic, former FDA Principal Deputy Commissioner Amy Abernethy said, but the agency needs to do a better job collecting postmarket data and communicating with the public. Accelerated authorization of COVID-19 vaccines during the pandemic demonstrated that FDA could continue to evaluate the data on a product after initial authorization, Abernethy said Tuesday (Nov. 15) at the HLTH Conference in Las Vegas. “What that story told us is...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.